Atul Pande, Director at Immunovant, Inc. (IMVT), sold 24,700 shares at $38.80 ($981K) on 2023-12-01, disclosed to the SEC on 2023-12-05.
Scheduled sale ($981k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.80 | 4,129 | $160K | 16.3% |
| 2 | $38.80 | 4,129 | $160K | 16.3% |
| 3 | $39.82 | 3,374 | $134K | 13.7% |
| 4 | $39.82 | 3,374 | $134K | 13.7% |
| 5 | $40.46 | 4,847 | $196K | 20.0% |
| 6 | $40.46 | 4,847 |
| $196K |
| 20.0% |
| Total | $39.73 avg | 24,700 | $981K | 100% |
| Filing → |
| IMVT | SELL | 2026-06-26 | $57K | — | Filing → |
| IMVT | SELL | 2026-06-16 | $51K | — | Filing → |
| IMVT | SELL | 2026-05-20 | $192K | — | Filing → |